Q1 Revenue Plummets 18% Amid Major Customer Losses, Net Income Down 34%
Summary
Pacific Health Care Organization reported an 18% revenue decrease and a 34% net income drop in Q1 2026, largely due to the loss of major customers, with further material impacts anticipated.
Key Events
-
Significant Revenue Decline
Total revenues decreased by $321,110, or 18%, to $1,497,704 for the three months ended March 31, 2026, compared to $1,818,814 in the prior year. This was primarily due to a 62% drop in HCO revenue and a 100% decrease in 'Other' revenue, attributed to significant customer terminations.
-
Substantial Profitability Decrease
Net income fell by $98,994, or 34%, to $193,669 in Q1 2026 from $292,663 in Q1 2025. Income from operations also decreased by $141,735, or 45%, reflecting the revenue challenges.
-
High Customer Concentration Risk
Three major customers accounted for approximately 49% of total sales in Q1 2026. The company disclosed two significant customer terminations (October 2024 and January 2026) that are expected to materially impact operating revenues in future periods.
-
Mixed Segment Performance
Utilization review revenue increased by 9% due to increased referrals, and employee advocate services grew by 15%, partially offsetting declines in other service lines like HCO and medical bill review.
Analysis
Pacific Health Care Organization reported a substantial decline in Q1 2026 revenues and net income, primarily driven by the loss of significant customers. The company explicitly stated that two major customer terminations, one in October 2024 and another in January 2026, are expected to continue to materially impact future operating revenues. This high customer concentration (49% from three customers) poses a significant ongoing risk to the company's financial stability and growth prospects. While management asserts sufficient liquidity for the next twelve months, the sharp decline in profitability and the forward-looking negative impact of customer churn warrant close monitoring by investors.
At the time of this filing, PFHO was trading at $1.23 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $15.7M. The 52-week trading range was $0.65 to $1.49. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.